Pages that link to "Q39559565"

The following pages link to Combined treatment with EGFR inhibitors and arsenite upregulated apoptosis in human EGFR-positive melanomas: a role of suppression of the PI3K-AKT pathway (Q39559565):

Displaying 24 items.

• Melanoma: from mutations to medicine (Q27024061) ‎ (← links)
• Store-operated Ca2+ entry (SOCE) regulates melanoma proliferation and cell migration (Q27321085) ‎ (← links)
• Influence of arsenate and arsenite on signal transduction pathways: an update (Q34024633) ‎ (← links)
• IL-24 gene transfer sensitizes melanoma cells to erlotinib through modulation of the Apaf-1 and Akt signaling pathways (Q34154783) ‎ (← links)
• Regulation of apoptosis in human melanoma and neuroblastoma cells by statins, sodium arsenite and TRAIL: a role of combined treatment versus monotherapy (Q35213333) ‎ (← links)
• Tetramethylpyrazine (TMP) protects against sodium arsenite-induced nephrotoxicity by suppressing ROS production, mitochondrial dysfunction, pro-inflammatory signaling pathways and programed cell death. (Q35226559) ‎ (← links)
• Suppression of the proinflammatory response of metastatic melanoma cells increases TRAIL-induced apoptosis (Q35230726) ‎ (← links)
• Annotation of human cancers with EGFR signaling-associated protein complexes using proximity ligation assays (Q35631966) ‎ (← links)
• NF-kappaB activation in melanoma (Q36416479) ‎ (← links)
• Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer (Q36614997) ‎ (← links)
• Sensitivity to sodium arsenite in human melanoma cells depends upon susceptibility to arsenite-induced mitotic arrest. (Q36775161) ‎ (← links)
• Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells (Q37390867) ‎ (← links)
• Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. (Q38309479) ‎ (← links)
• 2,3,5,6-Tetramethylpyrazine (TMP) down-regulated arsenic-induced heme oxygenase-1 and ARS2 expression by inhibiting Nrf2, NF-κB, AP-1 and MAPK pathways in human proximal tubular cells. (Q38832666) ‎ (← links)
• EGFR inhibitor enhances cisplatin sensitivity of human glioma cells (Q39427603) ‎ (← links)
• Calcium-induced apoptosis is delayed by HER1 receptor signalling through the Akt and PLCγ pathways in bladder cancer cells. (Q39630184) ‎ (← links)
• The epidermal growth factor family has a dual role in deciding the fate of cancer cells. (Q40209050) ‎ (← links)
• Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1/R2 surface levels and downregulation of cFLIP expression. (Q40214713) ‎ (← links)
• Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells (Q40314772) ‎ (← links)
• Serum epidermal growth factor receptor levels in patients with malignant melanoma (Q46840133) ‎ (← links)
• Stability, complexity and robustness in population dynamics. (Q51059615) ‎ (← links)
• Transcriptional regulation of Δ6-desaturase by peroxisome proliferative-activated receptor δ agonist in human pancreatic cancer cells: role of MEK/ERK1/2 pathway. (Q54393261) ‎ (← links)
• SIRT2 Contributes to the Resistance of Melanoma Cells to the Multikinase Inhibitor Dasatinib. (Q64937213) ‎ (← links)
• The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas (Q89456689) ‎ (← links)